Table 2.
Rate | Var. | CHf | n | Rmax | Property and comments |
---|---|---|---|---|---|
Roxy | coxy | 1 μM | 1 | −0.034 mol/m3/s | Oxygen consumption, basic part. Cut to 0 below critical value, coxy < Ccr,oxy. |
Roxy | cgluc | 7 mM | 2.5 | N/A | Oxygen consumption, φo,g metabolic part. Follows increase in metabolic demand; parallels second-phase insulin secretion rate. |
Rgluc | cgluc | 10 μM | 1 | −0.028 mol/m3/s | Glucose consumption. Under most conditions, it has no significant influence on insulin secretion. |
Rins,ph2 | cgluc | 7 mM | 2.5 | H: 1.8×10−5 mol/m3/s M: 3×10−5 mol/m3/s |
Insulin secretion rate (second-phase). Total secretion rate is modulated by local oxygen availability (last row). H and M denote values used for human and murine islets, respectively. |
Rins,ph1 | c′t (∂cgluc/∂t) | 0.03 mM/s | 2 | H: 10×10−5 mol/m3/s M: 21×10−5 mol/m3/s |
Insulin secretion rate (first-phase). Modulated to have maximum sensibility around cgluc = 5 mM and be limited at very large or low cgluc. Hill slope of modulating function, σi1,g, changed to 2.5 (previously 4) for a wider range response in phase 1. Release rates kinsL are H: 0.003, M: 0.006 s−1. |
Rins, φo,g | coxy | 3 μM | 3 | N/A | Oxygen modulation of insulin secretion rate, φo,g. Limits insulin secretion if coxy becomes critically low. |